Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Hypertension. 2013 Feb 25;61(4):842–849. doi: 10.1161/HYPERTENSIONAHA.111.00080

Figure 7.

Figure 7

Quantitative comparison of the mRNA expression for COX-1 and COX-2 in the PVN of ANG II-infused rats treated early (A and B) or late (C and D) with PVN microinjections of p44/42 MAPK siRNA, a scrambled siRNA, or vehicle. Untreated rats served as Control. Values are mean ± SEM (n = 6-8 for each group). *P< 0.05, vs. Control.